GlaxoSmithKline
GSK
$35.06
Share price
-0.11%
Change (1 day)
-19.01%
Change (1 year)
Categories
Operating Margin for GlaxoSmithKline (GSK)
Operating Margin as of March 2023 (TTM): 19.52%
According to GlaxoSmithKline's latest financial reports and stock price the company's current Operating Margin is 19.52%. At the end of 2021 the company had an Operating Margin of 18.23%.
Operating Margin history for GlaxoSmithKline from 2001 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | 18.23% | -20.55% |
| 2020 | 22.94% | 8.99% |
| 2019 | 21.05% | 16.47% |
| 2018 | 18.08% | 28.05% |
| 2017 | 14.12% | 48.22% |
| 2016 | 9.52% | -79.77% |
| 2015 | 47.07% | 195% |
| 2014 | 15.96% | -42.75% |
| 2013 | 27.87% | -1.15% |
| 2012 | 28.19% | -9.13% |
| 2011 | 31.03% | 120.88% |
| 2010 | 14.05% | -54.06% |
| 2009 | 30.58% | -0.75% |
| 2008 | 30.81% | -14.58% |
| 2007 | 36.06% | 7.28% |
| 2006 | 33.62% | 1901.06% |
| 2005 | 1.68% | -94.44% |
| 2004 | 30.21% | 1.33% |
| 2003 | 29.81% | 10.7% |
| 2002 | 26.93% | -9.4% |
| 2001 | 29.72% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Novartis NVS | 16.15% | -17.26% | 🇨🇭 Switzerland |
 Pfizer PFE | 29.90% | 53.18% | 🇺🇸 USA |
 Sanofi SNY | 19.90% | 1.95% | 🇫🇷 France |
 Merck MRK | 28.49% | 45.95% | 🇺🇸 USA |
 AstraZeneca AZN | -0.70% | -103.59% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | 4.14% | -78.79% | 🇮🇱 Israel |
 Dynavax Technologies
DVAX | 17.64% | -9.63% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.